SAN DIEGO, Nov. 27, 2017 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) is pleased to announce that its Chief Executive Officer, Ms. Reggie Groves, is scheduled to present at the 29th Annual Piper Jaffray Healthcare Conference on Tuesday, November 28, 2017, at 2:10 p.m. US EST. The conference is being held at the Lotte New York Palace in New York City.

The presentation materials to be delivered at the conference are available in the Investor Relations section of REVA’s website at www.revamedical.com.

About REVA Medical
REVA Medical is a medical device company focused on the development and commercialization of bioresorobable polymer technologies for vascular applications. The Company’s lead product, the Fantom bioresorbable scaffold, received European CE Mark on April 3, 2017 for the treatment of coronary artery disease. REVA is located in San Diego, California, USA and employs over 50 people in the United States and Europe.